Skip to main content
European Commission logo
Enterprise Europe Network

INNOVATİVE ENZYME ENGİNEERİNG SOLUTİONS FOR A SUSTAİNABLE FUTURE

Summary

Profile Type
  • Business Offer
POD Reference
BOTR20250417006
Term of Validity
17 April 2025 - 17 April 2026
Company's Country
  • Türkiye
Type of partnership
  • Commercial agreement
  • Supplier agreement
  • Investment agreement
  • Outsourcing agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
MBBIOTECH is a start-up company founded in 2025 by Dr. Yunus Ensari with the vision of producing biotechnological solutions for a sustainable future. With our expertise in enzymes and enzyme engineering, we offer innovative and environmentally friendly approaches to the challenges faced by industries.
Full Description
MBBIOTECH is an innovative start-up company founded in 2025 by Dr. Yunus Ensari, with the vision of developing biotechnological solutions for a sustainable future. Specializing in enzyme engineering and molecular biotechnology, MBBIOTECH is comprised of a dynamic team with over a decade of academic and industrial experience. Our goal is to merge scientific knowledge with industry demands to create advanced, environmentally friendly solutions inspired by nature. We offer a wide range of products and services, including enzyme identification, gene cloning and recombinant protein production, protein engineering, biocatalysis, computational biology, and scientific/project consultancy. With our deep expertise in enzyme engineering and a strong R&D foundation, we develop customized biotechnological solutions tailored to the specific needs of various industrial sectors.

At MBBIOTECH, our mission is to contribute to making industries more sustainable, efficient, and competitive through innovative, nature-inspired biotechnological applications. In line with this mission, we embrace a collaborative approach at both national and international levels, aiming to transform science into societal value. Our vision is to become a globally recognized and pioneering company in the field of enzyme engineering and biotechnology, leading technological advancements and contributing to environmental sustainability.

Our core values guide all our activities: Sustainability, which means developing solutions that are sensitive to the environment and society; Innovation, through continuous development and application of new technologies; Customer-Centricity, by offering the most suitable solutions for our clients’ needs; and Scientific Excellence, by adhering to the highest standards of scientific integrity and accuracy. MBBIOTECH is committed to building the biotechnology of the future today, creating added value both scientifically and environmentally.
Advantages and Innovations
At MBBIOTECH, we utilize the latest technologies and innovative approaches in our enzymology research. In this context, we employ in silico techniques and bioinformatics tools to identify novel and potential enzyme candidates from extensive databases.
Stage of Development
  • Lab tested
Sustainable Development Goals
  • Goal 7: Affordable and Clean Energy
  • Goal 1: No Poverty
  • Goal 3: Good Health and Well-being

Partner Sought

Expected Role of a Partner
Our expectations from potential partners include participation in joint R&D projects in enzyme engineering and biotechnology, supporting the development and application of technologies, providing testing platforms, sharing knowledge, and collaborating on funding applications. Our goal is to establish mutually beneficial partnerships that drive sustainable and innovative solutions.
Type and Size of Partner
  • SME <=10
Type of partnership
  • Commercial agreement
  • Supplier agreement
  • Investment agreement
  • Outsourcing agreement

Dissemination

Market keywords
  • 04007 - Enzymology/Protein Engineering/Fermentation
  • 04008 - Genetic Engineering
  • 04010 - Microbiology
  • 04005 - Biochemistry / Biophysics
  • 04004 - Other Genetic Engineering
Targeted countries
  • All countries